{"id":355958,"date":"2025-08-07T14:00:24","date_gmt":"2025-08-07T08:30:24","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=355958"},"modified":"2025-08-07T14:00:03","modified_gmt":"2025-08-07T08:30:03","slug":"cyril-amarchand-advices-astec-lifesciences-rights-issue","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","title":{"rendered":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Cyril Amarchand Mangaldas advised Astec LifeSciences (a subsidiary of Godrej Agrovet) on the rights issue of equity shares. The deal size was INR 2,382.00 million approx. The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on July 31, 2025.<\/p>\n<p style=\"margin-bottom: 3%;\">The transaction was led by <span style=\"font-weight: bold;\">Yash Ashar<\/span>, Senior Partner; <span style=\"font-weight: bold;\">Devaki Mankad<\/span>, Partner, Regional Co-Head &#8211; Capital Markets \u2014 West; and <span style=\"font-weight: bold;\">Abhyuday Bhotika<\/span>, Partner; with support from <span style=\"font-weight: bold;\">Veena Raghav<\/span> Senior Associate Designate; <span style=\"font-weight: bold;\">Anna Kallivayalil<\/span>, Associate; and<span style=\"font-weight: bold;\"> Mahima Aggarwal<\/span>, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on July 31, 2025.<\/p>\n","protected":false},"author":67011,"featured_media":355966,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[86818,86270,30960,35087,86819,41294],"class_list":["post-355958","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-astec-lifesciences","tag-capital-raise","tag-cyril-amarchand-mangaldas","tag-equity-shares","tag-godrej-agrovet","tag-rights-issue"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Cyril Amarchand Mangaldas Advises Astec LifeSciences on INR 2,382 Mn Rights Issue | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T08:30:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares\",\"datePublished\":\"2025-08-07T08:30:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/\"},\"wordCount\":93,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Astec-LifeSciences-rights-issue.webp\",\"keywords\":[\"Astec LifeSciences\",\"Capital Raise\",\"Cyril Amarchand Mangaldas\",\"equity shares\",\"Godrej Agrovet\",\"Rights Issue\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/\",\"name\":\"Cyril Amarchand Mangaldas Advises Astec LifeSciences on INR 2,382 Mn Rights Issue | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Astec-LifeSciences-rights-issue.webp\",\"datePublished\":\"2025-08-07T08:30:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Astec-LifeSciences-rights-issue.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Astec-LifeSciences-rights-issue.webp\",\"width\":886,\"height\":590,\"caption\":\"Astec LifeSciences rights issue\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/08\\\/07\\\/cyril-amarchand-advices-astec-lifesciences-rights-issue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas Advises Astec LifeSciences on INR 2,382 Mn Rights Issue | SCC Times","description":"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares","og_description":"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-08-07T08:30:24+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares","datePublished":"2025-08-07T08:30:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/"},"wordCount":93,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp","keywords":["Astec LifeSciences","Capital Raise","Cyril Amarchand Mangaldas","equity shares","Godrej Agrovet","Rights Issue"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","name":"Cyril Amarchand Mangaldas Advises Astec LifeSciences on INR 2,382 Mn Rights Issue | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp","datePublished":"2025-08-07T08:30:24+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advised Astec LifeSciences, a Godrej Agrovet subsidiary, on its INR 2,382 million rights issue of equity shares.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp","width":886,"height":590,"caption":"Astec LifeSciences rights issue"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/355958","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=355958"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/355958\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/355966"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=355958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=355958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=355958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}